1
Open
[.]
2
Close
[.]
3
Allotment
—
4
Listing
[.]
Issue Size
34,29,000 shares (agg. up to ₹[.] Cr)
Listing Date
[.]
✦ AI Insight
Restated Financials (₹ Cr.)
| Period Ended | 31 Dec 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
|---|---|---|---|---|
| Assets | 26.27 | 32.96 | 51.35 | 61.03 |
| Total Income | 3.50 | 29.61 | 41.39 | 36.42 |
| Profit After Tax | 0.09 | 0.71 | 1.66 | 3.32 |
| EBITDA | 8.99 | 6.89 | 4.05 | 0.24 |
| NET Worth | 9.58 | 6.30 | 4.62 | 0.09 |
| Reserves and Surplus | 7.67 | 4.35 | 2.70 | 0.09 |
| Total Borrowing | 39.67 | 35.83 | 20.99 | 20.64 |
| Amount in ₹ Crore |
Peer Comparison
| Company | Issue Type | Issue Size | Issue Price | PE Ratio | Listing Day Close | Listing Gain/Loss % | LTP |
|---|---|---|---|---|---|---|---|
| Bio Medica Laboratories Ltd. | SME | ₹52.43 Cr | ₹139 | 13.03 | ₹115.80 | -16.69% | ₹138.70 (-0.18%) |
| Goldline Pharmaceutical Ltd. | SME | ₹11.61 Cr | ₹43 | 10.47 | ₹56.77 | +32.02% | ₹38.13 (-4.65%) |
| Speciality Medicines Ltd. | SME | ₹29.14 Cr | ₹124 | 9.27 | ₹125.90 | +1.53% | ₹185.00 (+0.00%) |
| Accretion Nutraveda Ltd. | SME | ₹24.77 Cr | ₹129 | 26.27 | ₹191.20 | +48.22% | ₹273.75 (+0.09%) |
| KRM Ayurveda Ltd. | SME | ₹77.49 Cr | ₹135 | 17.32 | ₹180.70 | +33.85% | ₹255.30 (+2.51%) |
| Curis Lifesciences Ltd. | SME | ₹27.52 Cr | ₹128 | 12.44 | ₹141.00 | +10.16% | ₹112.00 (+1.82%) |
| Aptus Pharma Ltd. | SME | ₹13.02 Cr | ₹70 | 11.29 | ₹84.84 | +21.20% | ₹254.50 (+1.13%) |
| Hexagon Nutrition Ltd. | Mainboard | ₹138.87 Cr | ₹45 | 22.69 | ₹53.19 | +18.20% | ₹65.51 (+1.93%) |
| Sai Parenteral's Ltd. | Mainboard | ₹408.79 Cr | ₹392 | 72.19 | ₹405.70 | +3.49% | ₹535.60 (-0.34%) |
| Corona Remedies Ltd. | Mainboard | ₹655.37 Cr | ₹1062 | 43.47 | ₹1,438.40 | +35.44% | ₹2,113.00 (+4.28%) |
| Rubicon Research Ltd. | Mainboard | ₹1,377.50 Cr | ₹485 | 55.75 | ₹628.20 | +29.53% | ₹1,520.20 (-0.78%) |
| Amanta Healthcare Ltd. | Mainboard | ₹126.00 Cr | ₹126 | 34.59 | ₹141.75 | +12.50% | ₹163.00 (-0.61%) |
| Anlon Healthcare Ltd. | Mainboard | ₹121.03 Cr | ₹91 | 17.67 | ₹91.73 | +0.80% | ₹15.01 (-0.40%) |
Objects of the Issue
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Repayment / prepayment, in part or full, of certain of our borrowings | 17.00 |
| 2 | Funding our Working Capital Requirements; and | 4.30 |
| 3 | Funding inorganic growth through unidentified acquisitions and general corporate purposes (collectively referred to as “Objects”) |
About ABH Healthcare IPO
ABH Healthcare Ltd provides healthcare services, operates under the name "Anil Baghi Hospital". The company has 150 beds and offer 25 medical specialities, including cardiac sciences, neurology, minimally invasive spine and brain surgeries, medical and surgical gastroenterology, laparoscopic and bariatric surgery, urology, pulmonology, nephrology, ENT, maxillofacial surgeries, etc. The hospital has empaneled with 30 private and public health insurance providers and third-party administrators. We also participate in major government healthcare schemes such as the Ex-Servicemen Contributory Health Scheme (ECHS), Railways, Food Corporation of India (FCI), Bharat Sanchar Nigam Limited (BSNL), and Ayushman Bharat - Sarbat Sehat Bima Yojana (ABSSBY). As of March 31, 2025, it has 29 doctors and 137 nurses. Competitive Strengths Doctor led professional management team with proven execution capabilities Best quality clinical care by attracting and retaining experienced and renowned clinicians Diversified operations across clinical specialties Robust operating infrastructure including information technology and modern equipments Track record of stable operating and financial performance and
Contact Details
ABH Healthcare Ltd. AddressAnil Baghi Road, Ferozepur,PunjabFirozpur, Punjab, 152002+91 7888690018investor@anilbaghihospital.comVisit Website